Literature DB >> 17391422

The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study.

Bernd Brüggenjürgen1, Karin Rossnagel, Stephanie Roll, Fredrik L Andersson, Dagmar Selim, Jacqueline Müller-Nordhorn, Christian H Nolte, Gerhard J Jungehülsing, Arno Villringer, Stefan N Willich.   

Abstract

OBJECTIVES: Atrial fibrillation (AF) is an important risk factor for stroke. The primary purpose of this study was to determine the resource use for patients admitted to hospital with acute stroke and to calculate stroke-related direct costs, stratifying the results according to the presence of AF as a risk factor.
METHODS: Data from 558 consecutive patients hospitalized with confirmed acute stroke between August 2000 and July 2001 were analyzed as part of the Berlin Acute Stroke Study. Sociodemographic variables were assessed by direct interview, while hospital data were derived from patient medical records. Patients or their carers completed a follow-up questionnaire about resource utilization and absenteeism from work during the 12-month period after hospital admission.
RESULTS: Out of the 367 patients with follow-up data and ECG findings, 71 (19%) had AF. Patients with AF were generally older, more likely to be female, and had more severe strokes compared with those without AF. Mean direct costs per patient were significantly higher in those with AF-related strokes (EURO 11,799 vs EURO 8817 for non-AF-related strokes; P < 0.001). After adjustment for confounding factors, direct costs were comparable in the two groups, except for acute hospitalization costs, which remained significantly higher in the group with AF (P < 0.05).
CONCLUSION: Medical care for stroke patients with AF is associated with higher costs compared with those without AF; this is explained mainly by confounding factors and driven essentially by a significant difference in acute hospitalization costs.

Entities:  

Mesh:

Year:  2007        PMID: 17391422     DOI: 10.1111/j.1524-4733.2006.00160.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  29 in total

1.  Identification of patients with atrial fibrillation in UK community pharmacy: an evaluation of a new service.

Authors:  M J Twigg; T Thornley; N Scobie
Journal:  Int J Clin Pharm       Date:  2016-04-23

Review 2.  The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?

Authors:  Dawood Darbar
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

3.  Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation.

Authors:  Alexander Mensch; Stephanie Stock; Björn Stollenwerk; Dirk Müller
Journal:  Pharmacoeconomics       Date:  2015-03       Impact factor: 4.981

Review 4.  Cost-Effectiveness of Atrial Fibrillation Ablation.

Authors:  Gulmira Kudaiberdieva; Bulent Gorenek
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 5.  Clinical and Economic Implications of AF Related Stroke.

Authors:  Ali N Ali; Ahmed Abdelhafiz
Journal:  J Atr Fibrillation       Date:  2016-02-29

6.  Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.

Authors:  Kostas Athanasakis; Eleftheria Karampli; Dimitrios Tsounis; Aikaterini Bilitou; John Kyriopoulos
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

Review 7.  Cost effectiveness of antiarrhythmic medications in patients suffering from atrial fibrillation.

Authors:  Bernd Brüggenjürgen; Stefan Kohler; Nadja Ezzat; Thomas Reinhold; Stefan N Willich
Journal:  Pharmacoeconomics       Date:  2013-03       Impact factor: 4.981

Review 8.  Secondary stroke prevention strategies for the oldest patients: possibilities and challenges.

Authors:  Cheryl D Bushnell; Cathleen S Colón-Emeric
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

9.  Discontinuation of oral anticoagulation preceding acute ischemic stroke--prevalence and outcomes: Comprehensive chart review.

Authors:  Subba R Vanga; Sudhakar R Satti; James Williams; William Weintraub; Andrew Doorey
Journal:  Postgrad Med       Date:  2015-08-04       Impact factor: 3.840

10.  Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Authors:  Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.